Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma

por Sabado, Rachel L, Pavlick, Anna, Gnjatic, Sacha, Cruz, Crystal, Vengco, Isabelita, Hasan, Farah, Darvishian, Farbod, Chiriboga, Luis, Holman, Rose Marie, Escalon, Juliet, Muren, Caroline, Escano, Crystal, Yepes, Ethel, Sharpe, Dunbar, Adams, Sylvia, Ott, Patrick, Jungbluth, Achim, Pan, Linda, Venhaus, Ralph, Bhardwaj, Nina
Publicado 2013